Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Control of eosinophilia.

C J Sanderson1

  • 1National Institute for Medical Research, London, UK.

International Archives of Allergy and Applied Immunology
|January 1, 1991
PubMed
Summary

Interleukin-5 (IL5) is a key factor in eosinophil production, with in vivo studies indicating it dominates the control mechanism for eosinophilia, despite in vitro evidence of complex cytokine networks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Production of human and murine eosinophils in vitro and assay for eosinophil differentiation factors.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Transcription factor GATA-3 is involved in repression of promoter activity of the human interleukin-4 gene.

Biochemistry. Biokhimiia·2005
Same author

Dexamethasone suppresses human interleukin-5 gene promoter.

Bulletin of experimental biology and medicine·2005
Same author

Regulation of IL-5 expression.

Archivum immunologiae et therapiae experimentalis·2002
Same author

GATA-3 has dual regulatory functions in human interleukin-5 transcription.

The Journal of biological chemistry·2001
Same author

Binding of octamer factors to the murine IL-5 CLE0 in primary T-cells and a T-cell line.

Cytokine·2001

Area of Science:

  • Immunology
  • Hematopoiesis
  • Cell Biology

Background:

  • Eosinophil production involves complex cytokine interactions.
  • In vitro studies suggest multiple cytokines contribute to eosinophil development.
  • Interleukin-5 (IL5) has been identified as a potential key regulator.

Purpose of the Study:

  • To elucidate the role of IL5 in eosinophil production.
  • To compare in vitro and in vivo findings on cytokine control of eosinophilia.
  • To understand the network of cytokines involved in eosinophil differentiation.

Main Methods:

  • In vitro experiments assessing cytokine effects on eosinophil progenitors.
  • In vivo studies investigating the control mechanisms of eosinophilia.
  • Comparative analysis of experimental data.

Main Results:

  • In vitro studies indicate IL5 acts late in eosinophil production.
  • IL3 and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) are also involved in progenitor production and differentiation in vitro.
  • In vivo experiments reveal a simpler control mechanism dominated by IL5.

Conclusions:

  • Cytokine actions in eosinophilia exhibit significant redundancy in vitro.
  • IL5 appears to be the primary driver of eosinophilia in vivo.
  • A complex network of cytokines regulates eosinophil production in vitro, contrasting with the dominant role of IL5 in vivo.

Related Experiment Videos